Ali Behbahani's Net Worth

$62.6 Thousand

Estimate Recalculated Jun 10, 2025 09:31PM EST

Who is Ali Behbahani

Ali Behbahani does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Nkarta, Inc., NeueHealth, Inc., Monte Rosa Therapeutics, Inc., Oyster Point Pharma, Inc., NEVRO CORP, Mirum Pharmaceuticals, Inc., Adaptimmune Therapeutics PLC, CRISPR Therapeutics AG, GENOCEA BIOSCIENCES, INC., Metacrine, Inc., CVRx, Inc., Arcellx, Inc., Savara Inc, Trevi Therapeutics, Inc., MINERVA SURGICAL INC, Akouos, Inc., Black Diamond Therapeutics, Inc., Arsanis, Inc., Regulus Therapeutics Inc., Marker Therapeutics, Inc., and Korro Bio, Inc..

SEC CIK

Ali Behbahani's CIK is 0001613867

Past Insider Trading and Trends

2021 was Ali Behbahani's most active year for acquiring shares with 23 total transactions. Ali Behbahani's most active month to acquire stocks was the month of May. 2021 was Ali Behbahani's most active year for disposing of shares, totalling 10 transactions. Ali Behbahani's most active month to dispose stocks was the month of September. 2022 saw Ali Behbahani paying a total of $168,748.48 for 903,630 shares, this is the most they've acquired in one year. In 2023 Ali Behbahani cashed out on 36,525 shares for a total of $0.00, their largest year based on trade value.

Attention insiders:Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Nkarta, Inc.

Investor

Updated Jun 14, 2024


Form 4	—	22.50K	—	—	Jun 14, 2024	22.50K	Grant	—	Jun 13
Form 4	—	22.50K	—	—	Jun 09, 2023	22.50K	Grant	—	Jun 07
Form 4	—	16.00K	—	—	Jun 10, 2022	16.00K	Grant	—	Jun 08
Form 4	—	16.51K	—	—	Jun 15, 2021	16.51K	Grant	—	Jun 13
Form 4	—	10.70K	—	—	Jul 13, 2020	10.70K	Grant	—	Jul 09
Form 3	—	—	—	—	Jul 09, 2020	—	—	—	—


Form 4	—	618.64K	—	—	Apr 10, 2024	618.65K	Purchase	—	Apr 08
Form 4	11.85%	175.53K	—	—	Dec 21, 2023	1.66M	Purchase	—	Dec 19
Form 4	7.29%	100.61K	—	—	Nov 02, 2023	1.48M	Purchase	—	Oct 31
Form 4	66.67%	552.26K	—	—	Sep 19, 2023	1.38M	Purchase	—	Sep 15
Form 4	—	828.39K	—	—	Aug 15, 2023	828.40K	Purchase	—	Aug 11
Form 4	—	137.70K	$1,000.00	$137.70M	Oct 19, 2022	137.70K	Purchase	—	Oct 17
Form 4	—	200.00K	$1,000.00	$200.00M	Jan 05, 2022	200.00K	Purchase	—	Jan 03
Form 4	208.34%	48.59M	$18.00	—	Jun 30, 2021	71.91M	Purchase	—	Jun 28
Form 3	—	—	—	—	Jun 24, 2021	—	—	—	—


Form 4	—	22.10K	—	—	Jun 13, 2024	22.10K	Grant	—	Jun 12
Form 4	—	20.50K	—	—	Jun 15, 2023	20.50K	Grant	—	Jun 14
Form 4	—	15.00K	—	—	Jun 16, 2022	15.00K	Grant	—	Jun 15
Form 4	-67.20%	-15.76M	$19.00	—	Jun 30, 2021	7.69M	Buy-Options	—	Jun 28
Form 4	—	47.13K	—	—	Jun 25, 2021	47.13K	Grant	—	Jun 23
Form 3	—	—	—	—	Jun 23, 2021	—	—	—	—


Form 4	-100.00%	-24.20K	—	—	Jan 04, 2023	—	Disposition	—	Jan 03
Form 4	88.73%	8.93K	—	—	Jun 08, 2022	19.00K	Grant	—	Jun 06
Form 4	131.29%	8.66K	—	—	Jun 09, 2021	15.27K	Grant	—	Jun 07
Form 4	—	6.60K	—	—	Jun 10, 2020	6.60K	Grant	—	Jun 08
Form 3	—	—	—	—	Oct 30, 2019	—	—	—	—


Form 4	235.83%	3.79K	—	—	May 23, 2018	5.39K	Grant	—	May 21
Form 4	2.56%	40.00	—	—	Sep 15, 2017	1.61K	Acquisition	—	Sep 14
Form 4	10,772.34%	5.06K	—	—	May 30, 2017	5.11K	Grant	—	May 25
Form 4	88.00%	22.00	—	—	Nov 15, 2016	47.00	Acquisition	—	Nov 11
Form 4	—	3.24K	—	—	May 20, 2016	3.24K	Grant	—	May 18
Form 4	—	25.00	—	—	Dec 03, 2015	25.00	Acq/Dis	—	Dec 02
Form 4	—	4.18K	—	—	Jun 01, 2015	4.18K	Grant	—	May 28
Form 4	—	8.48K	—	—	Nov 07, 2014	8.48K	Grant	—	Nov 05
Form 3	—	—	—	—	Nov 05, 2014	—	—	—	—


Form 4	-47.77%	-2.00M	—	—	Jun 15, 2023	2.19M	Disposition	—	Jun 13
Form 4	-85.99%	-25.70M	$15.00	—	Jul 24, 2019	4.19M	Buy-Options	—	Jul 22
Form 3	—	—	—	—	Jul 17, 2019	—	—	—	—


Form 4	—	1.14M	—	—	Jul 01, 2024	1.14M	Grant	—	Jul 01
Form 4	—	40.95K	—	—	Jan 17, 2024	40.95K	Grant	—	Jan 15
Form 4	—	933.32K	—	—	Jul 03, 2023	933.32K	Grant	—	Jul 03
Form 4	—	737.05K	—	—	Jul 01, 2022	737.05K	Grant	—	Jul 01
Form 4	—	474.38K	—	—	Jul 02, 2021	474.39K	Grant	—	Jul 01
Form 4	—	184.26K	—	—	Jul 01, 2020	184.26K	Grant	—	Jul 01
Form 4	62.50%	7.50M	$0.67	$5.00M	Jan 28, 2020	19.50M	Purchase	—	Jan 24
Form 4	—	234.41K	—	—	Jul 03, 2019	234.41K	Grant	—	Jul 02
Form 4	—	12.00M	$1.67	$20.00M	Sep 10, 2018	12.00M	Purchase	—	Sep 07
Form 4	—	154.81K	—	—	Jun 26, 2018	154.81K	Grant	—	Jun 22
Form 4	—	220.79K	—	—	Jul 03, 2017	220.79K	Grant	—	Jul 03
Form 4	—	184.56K	—	—	Aug 12, 2016	184.56K	Grant	—	Aug 11
Form 3	—	—	—	—	Jan 04, 2016	—	—	—	—


Form 4	—	13.00K	—	—	May 31, 2024	13.00K	Grant	—	May 30
Form 4	—	13.00K	—	—	Jun 09, 2023	13.00K	Grant	—	Jun 08
Form 4	—	12.00K	—	—	Jun 10, 2022	12.00K	Grant	—	Jun 09
Form 4	—	10.00K	—	—	Jun 14, 2021	10.00K	Grant	—	Jun 10
Form 4	35.68%	71.00	—	—	Aug 14, 2020	270.00	Acquisition	—	Aug 13
Form 4	—	15.00K	—	—	Jun 15, 2020	15.00K	Grant	—	Jun 11
Form 4	—	15.00K	—	—	Jun 13, 2019	15.00K	Grant	—	Jun 11
Form 4	—	15.00K	—	—	Jun 15, 2018	15.00K	Grant	—	Jun 15
Form 4	—	199.00	—	—	May 15, 2018	199.00	Acq/Dis	—	May 14
Form 4	—	15.00K	—	—	Jun 02, 2017	15.00K	Grant	—	May 31
Form 4	—	30.00K	—	—	Oct 20, 2016	30.00K	Grant	—	Oct 18
Form 3	—	—	—	—	Oct 18, 2016	—	—	—	—


Form 4	-100.00%	-10.38M	$0.07	-$750.66K	May 26, 2022	—	Sale	—	May 24 - May 25
Form 4	—	15.00K	—	—	Jul 02, 2021	15.00K	Grant	—	Jul 01
Form 4	87.22%	6.30M	$1.19	$7.50M	Jul 28, 2020	13.53M	Purchase	—	Jul 24
Form 4	—	15.00K	—	—	Jun 19, 2020	15.00K	Grant	—	Jun 18
Form 4	—	5.63K	—	—	Jul 19, 2019	5.63K	Grant	—	Jul 18
Form 4	65.40%	2.86M	$3.50	$10.00M	Jun 25, 2019	7.23M	Purchase	—	Jun 24
Form 4	49.74%	12.44M	$0.30	$5.00M	Feb 19, 2019	37.44M	Purchase	—	Feb 14
Form 3	—	—	—	—	Jul 17, 2018	25.00M	—	—	—
Form 4	—	50.00K	—	—	Jun 25, 2018	50.00K	Grant	—	Jun 21
Form 4	—	25.00K	—	—	Feb 12, 2018	25.00K	Grant	—	Feb 08
Form 3	—	—	—	—	Feb 12, 2018	—	—	—	—


Form 4	-16.25%	-497.27K	$0.99	-$494.48K	Dec 27, 2021	2.56M	Sale	—	Dec 10 - Dec 22
Form 4	33.57%	769.23K	$13.00	—	Sep 22, 2020	3.06M	Purchase	—	Sep 18
Form 3	—	—	—	—	Sep 15, 2020	—	—	—	—


Form 4/A	—	27.25K	—	—	Jun 07, 2024	27.25K	Grant	—	Jun 04
Form 4	—	20.96K	—	—	Jun 06, 2024	20.96K	Grant	—	Jun 04
Form 4	—	—	$0.24	$74.89	Dec 18, 2023	316.00	Options	—	Dec 14
Form 4	-50.00%	-12.01K	—	—	Jun 07, 2023	12.01K	Grant	—	Jun 05
Form 4	—	26.98K	—	—	Jun 09, 2022	26.99K	Grant	—	Jun 07
Form 4	—	10.38K	—	—	Jul 01, 2021	10.38K	Grant	—	Jun 29
Form 3	—	—	—	—	Jun 29, 2021	—	—	—	—


Form 4	—	8.01K	—	—	Jun 06, 2024	8.01K	Grant	—	May 28
Form 4	—	11.46K	—	—	Jun 16, 2023	11.46K	Grant	—	Jun 14
Form 4	49.82%	141.00	—	—	Jun 05, 2023	424.00	Acquisition	—	Jun 01
Form 4	—	283.00	—	—	Dec 22, 2022	283.00	Acq/Dis	—	Dec 20
Form 3	—	—	—	—	Feb 03, 2022	—	—	—	—


Form 4	1.38%	333.33K	$3.00	$1.00M	Jul 19, 2023	24.47M	Purchase	—	Jul 17
Form 3	—	—	—	—	Mar 16, 2021	24.14M	—	—	—


Form 4	84.48%	6.58M	$1.90	$12.50M	Apr 13, 2022	14.37M	Purchase	—	Apr 11
Form 4	93.56%	5.56M	—	—	Oct 19, 2021	11.49M	Purchase	—	Oct 18
Form 4	-0.01%	-564.00	$2.66	-$0.24	Apr 13, 2020	5.94M	Sale	—	Apr 03
Form 4	-74.04%	-12.66M	$10.00	—	May 13, 2019	4.44M	Buy-Options	—	May 09
Form 3	—	—	—	—	May 07, 2019	—	—	—	—


Form 4	586.69%	49.79K	$2.41	$120.00K	Jun 14, 2022	58.28K	Grant	—	Jun 10
Form 4	—	—	—	—	Oct 28, 2021	8.49K	Options	—	Oct 26
Form 3	—	—	—	—	Oct 21, 2021	—	—	—	—


Form 4	-100.00%	-4.29M	—	—	Dec 02, 2022	—	Disposition	—	Nov 30
Form 4	15.87%	588.24K	$17.00	—	Jul 01, 2020	4.29M	Purchase	—	Jun 30
Form 3	—	—	—	—	Jun 25, 2020	—	—	—	—


Form 4	5.59%	2.89K	$4.98	$14.38K	Jun 21, 2024	4.50M	Grant	—	Jun 21
Form 4	—	30.55K	—	—	Jun 06, 2024	30.55K	Grant	—	Jun 06
Form 4	6.52%	3.17K	$4.54	$14.37K	Apr 03, 2024	4.50M	Grant	—	Mar 15
Form 4	10.11%	4.46K	$2.73	$12.16K	Dec 15, 2023	4.50M	Grant	—	Dec 15
Form 4	8.09%	3.30K	$3.60	$11.88K	Sep 18, 2023	4.49M	Grant	—	Sep 15
Form 4	29.00%	1.00M	$5.00	$5.00M	Jul 06, 2023	4.49M	Purchase	—	Jul 05
Form 4	16.10%	5.66K	$2.10	$11.88K	Jun 16, 2023	3.49M	Grant	—	Jun 16
Form 4	—	16.50K	—	—	May 17, 2023	16.50K	Grant	—	May 16
Form 4	25.39%	7.11K	$1.67	$11.88K	Mar 20, 2023	3.48M	Grant	—	Mar 16
Form 4	39.41%	7.92K	$1.50	$11.88K	Dec 19, 2022	3.48M	Grant	—	Dec 16
Form 4	29.14%	4.53K	$2.62	$11.87K	Sep 19, 2022	3.47M	Grant	—	Sep 16
Form 4	60.28%	5.85K	$2.03	$11.88K	Jun 17, 2022	3.46M	Grant	—	Jun 17
Form 4	—	15.00K	—	—	Jun 13, 2022	15.00K	Grant	—	Jun 10
Form 4	81.10%	4.35K	$3.02	$13.12K	Mar 18, 2022	3.46M	Grant	—	Mar 18
Form 4	85.63%	2.47K	$5.31	$13.13K	Dec 17, 2021	3.45M	Grant	—	Dec 17
Form 4	84.95%	1.33K	$9.90	$13.13K	Sep 23, 2021	3.45M	Grant	—	Sep 17
Form 4	2,927.61%	16.01K	$12.95	$13.13K	Jun 22, 2021	3.47M	Grant	—	Jun 18
Form 4	—	547.00	$24.01	$13.13K	Mar 22, 2021	3.45M	Grant	—	Mar 18
Form 4	-56.83%	-4.54M	$19.00	—	Feb 05, 2020	3.45M	Buy-Options	—	Feb 03
Form 3	—	—	—	—	Jan 29, 2020	—	—	—	—


Form 4	114.29%	5.71M	$1.75	$10.00M	Mar 18, 2021	10.71M	Purchase	—	Mar 16
Form 3	—	—	—	—	Oct 18, 2018	5.00M	—	—	—


Form 4	—	5.19K	—	—	Jun 12, 2024	5.19K	Grant	—	Jun 11
Form 4	1.66%	17.86K	$56.00	$999.99K	Apr 24, 2024	1.09M	Grant	—	Apr 22
Form 4	—	1.09M	—	—	Nov 07, 2023	1.09M	Grant	—	Nov 03
Form 3	—	—	—	—	Nov 07, 2023	—	—	—	—


Form 4	-90.35%	-33.83M	$16.00	—	Sep 17, 2024	3.61M	Buy-Options	—	Sep 16
Form 3	—	—	—	—	Sep 12, 2024	—	—	—	—

Ali Behbahani's Net Worth

Who is Ali Behbahani

SEC CIK

Past Insider Trading and Trends

Nkarta, Inc.

NeueHealth, Inc.

Monte Rosa Therapeutics, Inc.

Oyster Point Pharma, Inc.

NEVRO CORP

Mirum Pharmaceuticals, Inc.

Adaptimmune Therapeutics PLC

CRISPR Therapeutics AG

GENOCEA BIOSCIENCES, INC.

Metacrine, Inc.

CVRx, Inc.

Arcellx, Inc.

Savara Inc

Trevi Therapeutics, Inc.

MINERVA SURGICAL INC

Akouos, Inc.

Black Diamond Therapeutics, Inc.

Arsanis, Inc.

Regulus Therapeutics Inc.

Marker Therapeutics, Inc.

Korro Bio, Inc.

MBX Biosciences, Inc.